New drugs in neoadjuvant breast cancer therapy

Overall Survival with Pembrolizumab in Breast Cancer | NEJMПодробнее

Axillary management for breast cancer in the post-neoadjuvant settingПодробнее

Rates of pathologic complete response after neoadjuvant datopotamab deruxtecan in neoadjuvant br...Подробнее

Breast Cancer Breakthroughs Episode 6: Highlights from SABCS 2023Подробнее

NBE- NEOADJUVANT THERAPY AND DE-ESCALATION OF SURGICAL MANAGEMENT IN BREAST CANCER- DR. NITA NAIRПодробнее

OncoDaily Highlights from ESMO with Karima Oualla։ Breast cancer in Neoadjuvant SettingПодробнее

TROPION-Breast04: Dato-DXd and durvalumab in TNBC or HR-low/HER2- breast cancerПодробнее

Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Non-Carr...Подробнее

Rectum Cancer New Treatment Approach - Total Neoadjuvant Therapy - Know From Expert -Dr Pratik PatilПодробнее

Neoadjuvant Immune Therapy For ER Positive Breast Cancer – The Time Has ComeПодробнее

New study identifies promising drug combinations for triple negative breast cancer treatmentПодробнее

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Educational Sessions: "Approving new therapies for early breast cancer"Подробнее

Effectiveness of ICIs in the neoadjuvant and post-neoadjuvant breast cancer settingПодробнее

What's New in Screening and Treatment for Lobular Breast CancerПодробнее

The Future of Melanoma: What to Anticipate in 2023 with Neoadjuvant and Adjuvant PembrolizumabПодробнее

New Directions in the Treatment of Breast Cancer: Bringing Biology to the Clinic and BackПодробнее

Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Rectal cancer & total neoadjuvant therapy - RAPIDO trial, POLISH 2 and OPRA trial, PRODIGE 23 trialПодробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее